A 41-year-old woman with long-standing dermatomyositis comes to the physician for a follow-up examination. Two weeks ago, prednisone therapy was initiated because of an acute disease flare-up; this is her third course of prednisone during the past 18 months. The patient is currently feeling well. She is taking no other medications but takes a daily oral multivitamin. She is a non-smoker and non-drinker. BMI is 24. Vitals are normal. Physical examination shows mild roughness of both palms and violaceous papules on the knuckles. Which of the following is the most appropriate pharmacologic therapy for this patient?
Calcitonin
Cyclic progesterone therapy
Estrogen and progesterone
Raloxifene
Zoledronic acid
